Animal health segment
Eli Lilly and Company’s (LLY) animal health segment, Elanco, deals with products for companion animals as well as food and other products. The segment, which acquired Novartis (NVS) Animal Health, contributes ~15.0% to Lilly’s total revenues.
The animal health segment deals with the following products and services:
- food and other products
- pets or companion animal products
Revenues for animal health segment
US animal health revenues are expected to rise in 1Q17, mainly due to increased sales of new products added to the companion animal products. It will be partially offset by lower sales of swine and dairy products in US markets. International markets are also expected to report growth for food animal products and companion animal products in 1Q17.
Companion animal products
Revenues for companion animal products in 1Q17 are expected to rise due to increased sales of new products, including Interceptor Plus and Osurnia. International sales for companion animal products are expected to remain positive, resulting in overall revenue growth for companion animal products in 1Q17.
Food and other products
Revenues for food and other products are expected to rise in 1Q17 due to growth in sales of beef and poultry products in US markets. International sales are also expected to rise in 1Q17.
To divest the company-specific risks, you can consider ETFs such as the Health Care Select Sector SPDR ETF (XLV), which holds ~2.7% of its total assets in Eli Lilly, ~7.1% in Pfizer (PFE), ~6.3% in Merck & Co. (MRK), and ~1.0% in Zoetis (ZTS). You could also consider the iShares Core S&P 500 (IVV), which holds ~0.50% of its total assets in Eli Lilly.
Analysts estimate that PPL will report total revenues of $2.05 billion in 1Q17. In the corresponding quarter last year, it reported revenues of $2.01 billion.
Apple (AAPL) continues to receive challenges to its app business practices. After the US Supreme Court cleared a consumer-led antitrust lawsuit tied to Apple’s app business to proceed last month, a fresh lawsuit targeting the same business has been filed in California.
Cable giant Comcast (CMCSA) has shifted its focus to high-speed Internet, where it is gaining traction amid pay-TV decline.
A federal judge in California last month ruled that Qualcomm’s business practices stifled competition and ordered the company to change its business model. Qualcomm is expected to appeal the ruling. In the meantime, the company wants the ruling set aside until its appeal is heard.
On June 17, Nucor (NUE), the largest US-based steel producer, released its second-quarter earnings guidance. The company expects to post EPS of $1.20–$1.25 in the quarter. In contrast, it posted EPS of $1.63 in the first quarter and $2.13 in the second quarter of 2018.
Hardware technology stock Juniper (JNPR) has returned -5.7% in the last year, 7.7% in the last two years, 14.9% in the last three years, and 7.5% in the last five years, underperforming peers and broader markets. How can it break out of its slump?
On June 17, the Empire State Manufacturing Survey was released by the New York Fed. The index collapsed from 17.8 to -8.6 in June. The collapse was the highest on record, and the print was the first negative since October 2016. Economists had been expecting the reading to come in at 11.0.